Table 2. Adverse events reported.
| Preferred Term | Number of patients | Number of events |
| Diarrhoea | 3 | 13 |
| Chills | 4 | 11 |
| Fatigue | 8 | 17 |
| Influenza like illness | 4 | 17 |
| Injection site erythema | 4 | 10 |
| Injection site irritation | 5 | 6 |
| Injection site pain | 4 | 4 |
| Pyrexia | 6 | 17 |
| Myalgia | 3 | 18 |
| Arthralgia | 3 | 3 |
| Headache | 7 | 12 |
Only adverse events recorded in 3 patients or more have been listed in this table. A total of 196 AEs have been recorded, 179 of them were considered related to TG1042. All recorded adverse events were of grade 1 or 2 apart one grade 3 increase in blood lipase not considered related to TG1042.